Insiders · Profile

Ben-Noon Alon

Chief Executive Officer at NeuroSense Therapeutics. Filing since 16 Jun 2026. CIK 0001901198

Company

Date

Role

Action

Amount

Of holding

16 Jun 2026

Chief Executive Officer

Bought

250,000

$200.00K

5.8%

1 decision on file.